Navigation Links
Elsevier announces launch of Spatial and Spatio-temporal Epidemiology
Date:10/15/2009

Oxford UK, 15 October 2009 Elsevier, a world-leading publisher of scientific, technical and medical information products and services announced today the launch of a new peer-reviewed scientific journal, Spatial and Spatio-temporal Epidemiology (http://www.elsevier.com/locate/sste). The first issue was published in September 2009 and will be a primary forum for academics and scholars in the growing fields of graphical information systems, epidemiology, exposure science, and spatial statistics.

Spatial and Spatio-temporal Epidemiology will publish a broad range of topics relating to geospatial health methodology. The journal focuses on answering epidemiological questions where spatial and spatio-temporal approaches are appropriate to help advance our understanding of infectious and non-infectious diseases in humans. Veterinary topics will also be included. The journal places special emphasis on spatio-temporal aspects of emerging diseases (e.g., avian flu, SARS), development of spatial statistical and computational methods, and novel applications of geospatial technology (e.g., GPS, GIS) for shedding insights on exposure and disease processes.

The Editorial Board will be led by the internationally recognized scholar Professor Andrew B. Lawson, Division of Biostatistics & Epidemiology, College of Medicine, Medical University of South Carolina, USA.

"Spatial and Spatio-temporal Epidemiology is the premier vehicle for novel developments and advances in the area of geospatial health methodology," commented Professor Andrew B. Lawson, "In this outlet we hope to attract state of the art papers describing the latest advances in methodology in application to spatial and spatio-temporal epidemiology."

Jane Ma, Executive Publisher at Elsevier commented; "H1N1 is one of the world's greatest challenges for public health. It requires experts from a number of specialtie
'/>"/>

Contact: Rachel Guest
r.guest@elsevier.com
44-186-584-3825
Elsevier
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Elseviers Health Sciences Division and Peking University Medical Press cooperate on book donation
2. Elseviers leading mental health research now available in 1 place
3. Elsevier and Canadian College of Health Service Executives announce new publishing partnership
4. CHRISTUS Health Selects Five Elsevier Clinical Decision Support Solutions to Transform Care Delivery for Patients, Physicians, Nurses and Pharmacists
5. Gold Standard/Elsevier Launches MedCounselor Consumer Drug Information Modules
6. Elsevier partners with the Royal Colleges of Surgeons of Edinburgh and Ireland
7. Elsevier launches official version of BrainNavigator
8. The European Association for the Study of the Liver renews publishing partnership with Elsevier
9. Elsevier Launches SciVal Spotlight: New Tool Provides Multidisciplinary View of Research Performance
10. Elsevier Announces 2008 Journal Impact Factor Highlights
11. /C O R R E C T I O N -- Elsevier/
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... Cancer Institute and the Sanford-Burnham Medical Research Institute ... wholly owned member of the Roche group, and ... manufacture, develop and market human monoclonal antibodies to ... These viruses include the strains for the current ... have a non-exclusive right to manufacture, develop and ...
(Date:2/9/2010)... Rhonda Roby , ... University of North Texas Center for Human Identification ... instrumental in recently identifying three murder victims of the ... ,, The Chilean government contacted Roby in ... audit team of the victims, identification program for Patio ...
(Date:2/9/2010)... State University has launched the nation,s first comprehensive ... counterfeiting- which the FBI has called "the crime ... products- from pharmaceuticals to food additives to auto ... in global trade and has a major impact ... and national security. Terrorist and other organized crime ...
(Date:2/9/2010)... -- The first results from a large-scale study ... countries reveal that a high percentage of medicines ... and thus may contribute to the growth of ... most virulent form of malaria. The findings, released ... (PQM) Program, a USAID-funded program implemented by the ...
(Date:2/9/2010)... , Feb. 9 The Quantum Foundation ... the School District of Palm Beach County that ... fit. The Robert Wood Johnson Foundation (RWJF) recently announced a ... and access to affordable healthy foods for children and families ... communities. Based on a rigorous selection process that drew ...
Breaking Medicine News(10 mins):Health News:UNT Health Science Center's Roby Helps Identify Bodies of Chile's Patio 29 2Health News:UNT Health Science Center's Roby Helps Identify Bodies of Chile's Patio 29 3Health News:MSU launches first anti-counterfeiting research program 2Health News:MSU launches first anti-counterfeiting research program 3Health News:One-third of antimalarial medicines sampled in 3 African nations found to be substandard 2Health News:One-third of antimalarial medicines sampled in 3 African nations found to be substandard 3Health News:Planting Seeds to Fight Childhood Obesity 2
... is an early or predisposing event in the pathogenesis ... research which appears online on September 23 in the ... Myelodysplastic syndrome is a heterogeneous group of diseases ... hematopoietic lineages, clonal evolution and a tendency to progress ...
... been used widely in the treatment of hypertension ... hypertension guidelines. Moreover, after myocardial infarction and in ... blockers prevents re-infarction, hospitalisation for heart failure, and ... that atenolol is not very effective in hypertension. ...
... of bleeding from solid abdominal organs has been traditionally ... which has latelybeen recognized as detrimental. // Although there ... hemorrhage, bleeding is still the direct cause of death ... ,There is a continuous search for the "magical drug" ...
... has produced two Anti-retrovirals which can be used ... Nevirapine and Zidovudine is produced by CMSI in ... two drugs were officially released by Sebastian Ouseperamppil, ... which could maintain the quality control and Research ...
... Reddy Union Minister of Information, Broadcasting and Culture, India ... public regarding the prevention and treatment of HIV infections. ... social relevance. The media could play an important role ... the different broadcasting tools such as radio, websites, SMS, ...
... study, published in the October issue of the journal ... immune system abnormalities, including reduced levels of NKT cells, ... cells in the liver regulate production of cytokines, which ... may contribute to obesity -related liver disease. ,The ...
Other Medicine News:Health News:Evidence against use of Beta blockers as first choice in the treatment of primary hypertension 2Health News:Aprotinin in the treatment of hemorrhagic shock trauma patients 2Health News:Obesity As A Contributor To Liver Disease 2
(Date:2/8/2010)... Hanger Orthopedic Group, Inc. (NYSE: HGR ... of operations for the year ended December 31, 2009 ... Company plans to issue a press release announcing the results ... Wednesday, February 10, 2010 , after the close of ... 9:00 a.m., EST , on Thursday, February 11, ...
(Date:2/8/2010)... Heska Corporation (Nasdaq: HSKA ) announces the following Webcast: ,, (Logo: ... What: Heska Corporation Invites You to ... Year-End 2009 Earnings Conference Call on the Web, ... February 22, 2010 @ 1:00 p.m. (MST), , ... Earnings Call , ...
(Date:2/8/2010)... Fla. , Feb. 8 ... has signed an advertising contract with SkyMall Inc. ... is distributed in major airlines seat pockets. SkyMall ... copies. The advertisement featuring the MedFlash ® ... opposite the table of contents in the front ...
Breaking Medicine Technology:Hanger Orthopedic Group, Inc. Announces 2009 Year-End Earnings Release Conference Call 2Webcast Alert: Heska Announces Fourth Quarter and Year-End 2009 Earnings Conference Call Webcast 2Connectyx Announces MedFlash(R) Advertising Contract with SkyMall Inc. 2Connectyx Announces MedFlash(R) Advertising Contract with SkyMall Inc. 3Lilly Confirms Date and Conference Call For Fourth Quarter and Full Year 2009 Financial Results Announcement 7400 1Lilly Confirms Date and Conference Call For Fourth Quarter and Full Year 2009 Financial Results Announcement 7400 2Haiti Relief Site Now in Portuguese 64732 1Haiti Relief Site Now in Portuguese 64732 2Haiti Relief Site Now in Portuguese 64732 3President Obama Tasks Former Presidents Bush and Clinton with Fundraising for Haiti Recovery 64731 1President Obama Tasks Former Presidents Bush and Clinton with Fundraising for Haiti Recovery 64731 2President Obama Tasks Former Presidents Bush and Clinton with Fundraising for Haiti Recovery 64731 3
... 26 Pharmacopeia,(Nasdaq: PCOP ), an innovator ... therapeutics, today announced the completion of recruitment,in the ... (DARA),the company,s lead internal product candidate. The objective ... is to,evaluate the efficacy and safety of 200 ...
... Australia, Feb. 26 Bionomics Limited (ASX:,BNO) today announced ... Phase I trial of its anti-cancer drug, BNC105., ... patients with,advanced cancer. Patients will be treated with BNC105 ... over two cycles. The trial will be conducted at ...
Other Medicine Technology:Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA) 2Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA) 3Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA) 4Treatment of First Patient in Phase I Clinical Trial of Bionomics' Anti-Cancer Drug BNC105 2Treatment of First Patient in Phase I Clinical Trial of Bionomics' Anti-Cancer Drug BNC105 3
... advanced glass technologies and designs, the ... magnification views of the posterior pole. ... image quality previously unattainable with the ... more detailed and comprehensive views, helping ...
... autoimmune testing feature single-well ANA screen and ... reflex tests including dsDNA, and 6 individual ... (La), Scl-70 and Jo-1. In addition, our ... of products for Cardiolipins (IgA, IgG, IgM), ...
... ELISA products for autoimmune testing feature single-well ... well as specific reflex tests including dsDNA, ... SS-A (Ro), SS-B (La), Scl-70 and Jo-1. ... a full line of products for Cardiolipins ...
... Peel PRESTIGE system was designed with advanced ... of the most demanding skin care practice. ... the Parisian Peel PRESTIGE machine is designed ... to offer maximum versatility and full abrasion ...
Medicine Products: